Skip to main content

Advertisement

Log in

Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction

  • Kidneys, Ureters, Bladder, Retroperitoneum
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Objective

To determine the potential predictors of antegrade ureteral stenting (AUS) failure in patients with malignant and benign ureteral obstruction.

Method

We retrospectively evaluated 116 AUS procedures performed in 80 patients for ureteral obstruction due to malignant and benign causes. Variables such as etiology for obstruction, ureter shape, previous treatment regimen, history of ileal loop diversion, and presence of percutaneous nephrostomy were recorded. Univariate and multivariate logistic regression methods were used between these variables and stent failure.

Results

Antegrade ureteral stenting was performed as single stage in 24 procedures (n: 24/116, 21%) and performed as a two-step approach after percutaneous nephrostomy in 92 procedures (n: 92/116, 79%). Ureteral stent was successfully deployed in 112 AUS procedures (n: 112/116, 96.5%). In 35 of these successful procedures, the patients were referred to our department due to prior failed retrograde ureteral stenting (RUS). Subsequent stent failure occurred in 40 procedures after a median interval of 39 days. Pre-stenting percutaneous nephrostomy (PN) was a statistically significant risk factor for stent failure (p: 0.041), and age showed an inverse relationship with stent failure (p: 0.008). Complications in early (within the first 30 days after procedure) and late stage occurred in a total of 17 procedures. Early complications included urinary tract infection (n: 11), stent migration (n: 3), and malposition (n: 1). Late complications (after 30 days) were urinary tract infection (n: 1) and stent migration (n: 1).

Conclusion

This study suggests that AUS can be performed effectively in both benign and malignant ureteral obstructions including cases with prior failed RUS. Two-step AUS after percutaneous nephrostomy was found to be a significant risk factor for subsequent stent failure in our study cohort.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lynch, Mark F., et al. “Current opinion amongst radiologists and urologists in the UK on percutaneous nephrostomy and ureteric stent insertion for acute renal unobstruction: Results of a postal survey.” BJU International 98.6 (2006): 1143-1144.

  2. Hsu, Linda., et al. “Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction.” World Journal of Nephrology 5.2 (2016): 172-181.

  3. Chitale, S. V., et al. “The management of ureteric obstruction secondary to malignant pelvic disease.” Clinical Radiology 57.12 (2002): 1118-1121.

    Article  CAS  Google Scholar 

  4. Kim, Sung Han., et al. “Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.” PloS One 12.9 (2017): e0184965.

  5. Ganatra, Anjali M., et al. “The management of malignant ureteral obstruction treated with ureteral stents.” The Journal of Urology 174.6 (2005): 2125-2128.

    Article  Google Scholar 

  6. Hausegger, Klaus Armin., et al. “Percutaneous nephrostomy and antegrade ureteral stenting: technique—indications—complications.” European Radiology 16.9 (2006): 2016-2030.

  7. Dyer, Raymond B., et al. “Complications of ureteral stent placement.” Radiographics 22.5 (2002): 1005-1022.

  8. Nguyen, Hiep T., et al. “The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis.” Journal of Pediatric Urology, 6.3 (2010): 212-231.

    Article  Google Scholar 

  9. Matsuura, Hiroshi., et al. “Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.” International Journal of Clinical Oncology 24.3 (2019): 306-312.

    Article  CAS  Google Scholar 

  10. Kamiyama, Yoshihiro., et al. “Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors.” International Journal of Urology 18.5 (2011): 379-382.

  11. Yossepowitch, Ofer., et al. “Predicting the success of retrograde stenting for managing ureteral obstruction.” The Journal of Urology 166.5 (2001): 1746-1749.

  12. van der Meer, Rutger W., et al. “Antegrade ureteral stenting is a good alternative for the retrograde approach.” Current Urology 10.2 (2017): 87-91.

  13. Turgut, B., et al. “Placement of double-J stent in patients with malignant ureteral obstruction: antegrade or retrograde approach?” Clinical Radiology 74.12 (2019): 976.e11-976.e17.

    Article  CAS  Google Scholar 

  14. Kahriman, Guven., et al. “Percutaneous antegrade ureteral stent placement: single center experience.” Diagnostic and Interventional Radiology 25.2 (2019): 127-133.

  15. Bahu, Ramez., et al. “Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors.” The Journal of Urology 189.1 (2013): 130-135.

  16. Chung, Steve Y., et al. “15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.” The Journal of Urology 172.2 (2004): 592-595.

  17. Izumi, Kouji., et al. “Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction.” The Journal of Urology 185.2 (2011): 556-561.

  18. Yu, Seong Hyeon., et al. “Predicting factors for stent failure-free survival in patients with a malignant ureteral obstruction managed with ureteral stents.” Korean Journal of Urology 54.5 (2013): 316-321.

  19. Uthappa, M. C., et al. “Retrograde or antegrade double-pigtail stent placement for malignant ureteric obstruction?” Clinical Radiology 60.5 (2005): 608-612.

    Article  CAS  Google Scholar 

Download references

Funding

None to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Omer F. Nas.

Ethics declarations

Conflict of interest

All authors state that they have no conflict of interest to declare.

Ethical approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). This study was approved by the institutional ethics review of board.

Informed consent

All patients participating in the study have provided informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nas, O.F., Oztepe, M.F., Kandemirli, S.G. et al. Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction. Abdom Radiol 46, 2188–2194 (2021). https://doi.org/10.1007/s00261-020-02858-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02858-z

Keywords

Navigation